> Their observations will inform the development of Mount Sinai’s Tracheal Transplant Program, enabling Dr. Genden to offer this therapeutic approach to patients nationwide and internationally
This is without a doubt an impressive achievement.
Can someone speak to the logistics of expanding this program though? I don't suppose a 18 hour, 50 person procedure is in any way easy to coordinate, and I imagine it must be extremely expensive, both in terms of financial cost and time investment.
How feasible is it to propagate the expertise? Are there factors related to the novelty that make it attractive for other medical teams to invest time in training for this procedure? Is risk a deterrent in terms of insurance coverage?
As for logistics, it's probably not that different from transplanting another organ. In anything involving the trachea, the technical details of the procedure and the coordination between surgery and anesthesia is where the difficulty lies.
My wife worked as an Operating Room Nurse at a medium sized hospital for over 10 years.
There was also promising work on printing a biodegradable one that be used as a matrix or scaffold for growing a new one from the patient's own cells. This sounds like a better one; though you could print a non-immune-triggering one, one made of the patient's own cells would be more compliant (flexible) which I assume from taking animals apart is required for good breathing.